Deaths in COVID-19 cross 14,000 mark in Bangladesh

Deaths in COVID-19 cross 14,000 mark in Bangladesh

77 additional deaths recorded, more than 4,300 infections with daily infection rate at 22.5%, according to officials

By SM Najmus Sakib

DHAKA, Bangladesh (AA) - Bangladesh registered 77 additional deaths from the coronavirus on Saturday, taking the death toll to 14,053 with new hotspots outside the capital, Dhaka, particularly in border districts along India.

A total of 4,334 new infections were recorded, which took the caseload to 813,138, with the daily positivity rate of 22.50%, according to the Directorate General of Health Services (DGHS).

The National Technical Advisory Committee on COVID-19 has already suggested imposing a 14-day complete shutdown as the Delta variant has already spread across Bangladesh -- certainly in border districts.

Among the border districts; southwestern Jessore district witnessed as high as a 49.42% infection rate while the Dinajpur border district reported a 38% infection rate in recent hours as officials are fearing a third wave in the country.

The government, however, decided to impose a “harder” nationwide lockdown on Friday for one week starting Monday, amid a steady rise in infections and fatalities.

The closure of educational institutions will be extended as the government decided to impose a new lockdown. Schools have remained closed for 15 straight months since March 2020.

Meanwhile, Bangladesh will soon receive a gift of 2.5 million doses of the Moderna vaccine delivered through the multi-donor COVAX global initiative.

The US will donate 500 million Pfizer vaccines to 92 low- and lower-middle-income countries, including Bangladesh, according to the US Embassy in Dhaka.

Bangladesh is struggling to get vaccines amid surging infections as a supply from India was halted under an official agreement.



Kaynak:Source of News

This news has been read 184 times in total

ADD A COMMENT to TO THE NEWS
UYARI: Küfür, hakaret, rencide edici cümleler veya imalar, inançlara saldırı içeren, imla kuralları ile yazılmamış,
Türkçe karakter kullanılmayan ve büyük harflerle yazılmış yorumlar onaylanmamaktadır.
Previous and Next News